• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

HR22C16

CAS No. 462630-41-7

HR22C16 ( Monastroline )

产品货号. M14558 CAS No. 462630-41-7

A potent, selective and cell permeable inhibitor of mitotic kinesin Eg5 with IC50 of 0.8 uM.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥7857 有现货
50MG ¥16038 有现货
100MG ¥20250 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    HR22C16
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A potent, selective and cell permeable inhibitor of mitotic kinesin Eg5 with IC50 of 0.8 uM.
  • 产品描述
    A potent, selective and cell permeable inhibitor of mitotic kinesin Eg5 with IC50 of 0.8 uM, does not interact with other microtubule motor proteins; inhibits cell survival in both Taxol-sensitive and -resistant ovarian cancer cells with at least 15-fold greater efficacy than monastrol.
  • 同义词
    Monastroline
  • 通路
    Cytoskeleton/Cell Adhesion Molecules
  • 靶点
    Kinesin
  • 受体
    Kinesin
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    462630-41-7
  • 分子量
    389.46
  • 分子式
    C23H23N3O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    O=C(C1CC2=C(C(C3=CC=CC(O)=C3)N14)NC5=C2C=CC=C5)N(CCCC)C4=O
  • 化学全称
    2-butyl-5-(3-hydroxyphenyl)-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Hotha S, et al. Angew Chem Int Ed Engl. 2003 May 30;42(21):2379-82.
2. Marcus AI, et al. J Biol Chem. 2005 Mar 25;280(12):11569-77.
产品手册
关联产品
  • TCS-OX2-29

    TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.

  • TUG-891

    TUG-891 is a G protein-coupled receptor (GPCR) expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

  • Kif15-IN-1

    Kif15-IN-1 is a potent, selective inhibitor of KIF15 motility, can act synergistically with Eg5 inhibitors to impair cancer cell proliferation.